ACT Annual Meeting 2026

ACT 2026

ACT Annual Meeting 2026

Where Industry and Science Advance Toxicology Together

Join us at the 47th ACT Meeting, being held on November 15–18, 2026, in San Antonio, Texas.

The 47th Annual Meeting will include a wide-ranging scientific program, with distinguished plenary lectures discussing the reality of transitioning to NAMs, new in silico approaches and best practices in regulatory safety assesment.

ACT 2026

Meet us at Booth #514

We’d be glad to connect with you at the conference, hear your current goals, and discuss the applications of NAMs in early and regulatory safety assessment.

Paula van Rossum
Paula van Rossum, CBO at Toxys
Schedule a Meeting
Aaron Boswell
Aaron Boswell, Director of Business Development, USA

Don’t miss our Poster Presentations

Giel Hendriks
Mechanistic Follow-Up of In Vitro Micronucleus-Positive Compounds Using the ToxTracker Reporter Assay

Giel Hendriks, CEO at Toxys

Paula van Rossum
From Cytotoxicity to Teratogenicity: Challenges in Developmental Toxicity Assessment of Highly Cytotoxic Compounds

Paula van Rossum, CBO at Toxys

For an overview on our assays portfolio, you can visit our services and products page. We are happy to tell you more about them at the event.


Event location: San Antonio, Texas
Event website: Event website
Share